Introduction
============

Based on the GLOBOCAN 2008 estimates, breast cancer is the leading cause of cancer-related death in women worldwide. New cases of breast cancer are estimated to be 1,383,500 with 458,400 deaths ([@b1-mmr-05-04-1019]). Many prescriptions for chemotherapy have been derived from plants ([@b2-mmr-05-04-1019]). Danshen (*Salviae miltiorrhizae* radix) has been used in traditional Chinese medicine for cardiovascular disease and appeared in the Chinese book, Shennong Bencao Jing (ca. 100 A.D.) ([@b3-mmr-05-04-1019]). Tanshinone IIA (Tan-IIA) was extracted from danshen and was first described in 1968. It is known to have antioxidant ([@b4-mmr-05-04-1019]) and anti-inflammatory properties ([@b5-mmr-05-04-1019]). Our previous studies showed that Tan-IIA induces apoptosis in certain human cancer cells, such as human colon cancer colo 205 cells ([@b6-mmr-05-04-1019],[@b7-mmr-05-04-1019]), human hepatocellular carcinoma hep-J5 cells ([@b8-mmr-05-04-1019]), small-cell lung cancer H146 cells ([@b9-mmr-05-04-1019]) and non-small-cell lung cancer A549 cells ([@b10-mmr-05-04-1019]). Our previous study also showed that Tan-IIA inhibited MDA-MB-231 cells through inducing apoptosis by increasing Bax to Bcl-xL ratios and the protein levels of p21 and caspase-8 *in vitro* ([@b11-mmr-05-04-1019]). The anticancer effects of Tan-IIA on human breast cancer cell lines *in vitro* and *in vivo* have been well documented ([@b12-mmr-05-04-1019]--[@b15-mmr-05-04-1019]). However, the molecular mechanisms have not been fully elucidated. In the present study, we evaluated the effects and molecular mechanisms of Tan-IIA on MDA-MB-231 cells *in vitro* using a human breast cancer xenograft model in SCID mice.

Materials and methods
=====================

Chemicals
---------

Tan-IIA (molecular formula: C~19~H~18~O~3~, purity \>96% by HPLC) was purchased from Herbasin Co. (Shenyang, China). Corn oil, aprotinin, antipain, sodium deoxycholate, leupeptin, sodium orthovanadate, Triton X-100, Tris-HCl, ribonuclease-A and MTT \[3-(4,5-dimethylthiazol-2-y1)-2,5-diphenyltetrazolium bromide\] were obtained from Sigma Chemical Co. (St. Louis, MO, USA). Dimethyl sulfoxide (DMSO), potassium phosphates and TE buffer were purchased from Merck Co. (Darmstadt, Germany). L-15 medium, fetal bovine serum (FBS), penicillin-streptomycin, trypsin-EDTA and glutamine were obtained from Gibco BRL (Grand Island, NY, USA). The MDA-MB-231 human breast cancer cell line was obtained from the Food Industry Research and Development Institute (Hsinchu, Taiwan).

Cell culture
------------

The MDA-MB-231 human breast cancer cells were placed into 75-cm^3^ tissue culture flasks and grown at 37˚C in a humidified atmosphere (CO~2~ was not present) in L-15 medium (Sigma Chemical Co.) containing 10% heat-inactivated FBS, 1% penicillin-streptomycin (10,000 U/ml penicillin and 10 mg/ml streptomycin). The data presented herein are from a minimum of three independent experiments.

The protein expression of LC3-II and Erb-B2 in MDA-MB-231 cells treated with Tan-IIA was determined by western blotting. The cytotoxicity of Tan-IIA on MDA-MB-231 cells has been well documented ([@b11-mmr-05-04-1019]). The result showed that the proliferation of MDA-MB-231 cells was inhibited by Tan-IIA in a dose- and time-dependent manner. The IC~50~ was 11.85±0.29 μg/ml when MDA-MB-231 cells were treated with Tan-IIA for 48 h.

Protein preparation
-------------------

Approximately 1×10^6^ cells/10-cm dish were incubated with Tan-IIA at 0, 3, 10 and 25 μg/ml concentrations for 48 h before the cells were harvested by centrifugation. Protein was extracted as described ([@b16-mmr-05-04-1019]). Briefly, cell pellets were resuspended in modified RIPA buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Nonidet P-40, 0.25% sodium deoxycholate, 1 mM EGTA, 1 mM DTT, 1 mM PMSF, 1 mM sodium orthovanadate, 1 mM sodium fluoride, 5 μg/ml aprotinin, 5 μg/ml leupeptin and 5 μg/ml antipain) for 30 min at 4˚C. Lysates were immediately centrifuged at 13,000 × g for 20 min at 4˚C, and the supernatant was collected, aliquoated (50 μg/tube) and stored at −80˚C before being assayed. The protein concentrations were measured using the Bradford method ([@b17-mmr-05-04-1019]).

Effects of Tan-IIA on the expression of LC3-II, Erb-B2 and β-actin in MDA-MB-231 cells
--------------------------------------------------------------------------------------

All samples were separated by sodium dodecyl sulfate polyacrylamide (SDS-PAGE) gel electrophoresis (Bio-Rad Life Science Products, Hercules, CA, USA) as previously described ([@b16-mmr-05-04-1019]). The SDS separated proteins were followed by equilibration in transfer buffer (50 mM Tris, pH 9.0, 40 mM glycine, 0.375% SDS and 20% methanol) and electro-transferred to Immobilon-P Transfer membranes (Millipore Corporation, Bedford, MA, USA). The blot was then blocked with a solution containing 5% nonfat dry milk in Tris-buffered saline \[10 mM Tris and 150 mM NaCl (Sigma Chemical Co.)\], containing 0.05% Tween-20 for 1 h. It was then washed and incubated with antibodies to Erb-B2 (R&D), LC3-II (Sigma Chemical Co.) and β-actin (Upstate, Lake Placid, NY, USA) at 4˚C overnight. After incubating with anti-mouse peroxidase-conjugated antibody (Santa Cruz, Santa Cruz, CA, USA), the signal was visualized by enhanced chemiluminescence (ECL; Amersham Pharmacia Biotech). The detection of β-actin was used as an internal control in all the data for western blotting.

In vivo MDA-MB-231 cell tumor xenograft model
---------------------------------------------

Three-week-old female nude SCID mice (NOD.CB 17-Prkdcscid/Tcu) were xenografted with MDA-MB-231 human breast cancer cells (3×10^6^/0.2 ml) and maintained in a pathogen-free environment (Laboratory Animal Center of Tzu Chi University, Hualien, Taiwan). On day 28 onwards, the mice were divided randomly into three groups (each group n=7) to be treated with Tan-IIA (20 and 60 mg/kg of body weight, dissolved in corn oil). As a control, xenografted tumors were separately treated with corn oil (0.1 ml/10 g body weight). Each agent was administered orally every other day. At the end of the 3-month dosing schedule, the SCID mice were sacrificed by CO~2~ inhalation on the 97th day. After xenograft transplantation, mice exhibiting tumors were monitored, and the tumor size was measured once every 2 days using calipers. The tumor volume in each animal was estimated according to the formula: Tumor volume (mm^3^) = L × W^2^/2 (where L is the length and W is the width), with the final measurement taken 3 months after tumor cell inoculation. At the same time, the body weight of each animal was measured once every 2 days. The xenograft tumors were dissected and weighed individually, then the proteins were extracted for western blotting. The protein expression of NF-κBp65, caspase-3 and β-actin was measured by western blotting. Immunoreactive bands were scanned and analyzed using a digital scanning densitometer (Molecular Dynamics, Sunnyvale, CA, USA).

Statistical analysis
--------------------

Values are presented as the means ± SD. The Student\'s t-test was used to analyze the statistical significance and p\<0.05 was considered significant for all tests.

Results and Discussion
======================

The results showed that Tan-IIA significantly decreased the MDA-MB-231 cell xenograft tumor size ([Fig. 1](#f1-mmr-05-04-1019){ref-type="fig"}). An illustration of a representative animal treated with Tan-IIA relative to the control is shown in [Fig. 2A](#f2-mmr-05-04-1019){ref-type="fig"}. The results also showed that Tan-IIA (60 mg/kg) significantly decreased the weight of MDA-MB-231 cell xenograft tumors when compared to the control group ([Fig. 2B](#f2-mmr-05-04-1019){ref-type="fig"}). All MDA-MB-231 cell xenograft tumors appeared only at the inoculation sites (data not shown). Based on these results, Tan-IIA treatment (both 20 and 60 mg/kg body weight/per day) by oral administration inhibited MDA-MB-231 cell xenograft tumor growth. In the present study, mice with MDA-MB-231 xenograft tumors received Tan-IIA treatment; these tumors continue to grow slowly, indicating that multiple treatments are necessary to achieve a complete response. However, the results showed that a high dose of Tan-IIA had therapeutic potential in MDA-MB-231 cells *in vivo*. This is in agreement with other studies ([@b12-mmr-05-04-1019],[@b13-mmr-05-04-1019]). Our results showed that MDA-MB-231 cell xenograft tumors treated with Tan-IIA decreased NF-κBp65 ([Fig. 3A](#f3-mmr-05-04-1019){ref-type="fig"}), but increased caspase 3 expression ([Fig. 3B](#f3-mmr-05-04-1019){ref-type="fig"}) when compared to the control group. Our results also showed that MDA-MB-231 cells treated with Tan-IIA for 48 h decreased the protein expression of Erb-B2 ([Fig. 4A](#f4-mmr-05-04-1019){ref-type="fig"}) and LC3-II ([Fig. 4B](#f4-mmr-05-04-1019){ref-type="fig"}), but increased caspase 3 ([Fig. 4C](#f4-mmr-05-04-1019){ref-type="fig"}) expression. This is not in agreement with other studies, which showed that xenograft tumors treated with Tan-IIA decreased P53 and bcl-2 expression, but not of cerbB-2 ([@b12-mmr-05-04-1019],[@b13-mmr-05-04-1019]). The present study provides the first report of Tan-IIA anti-human breast cancer activity through a decrease in Erb-B2 and LC3-II expression *in vitro* and a decrease in NF-κBp65 expression in an MDA-MB-231 cell xenograft tumor model.
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Mice bearing MDA-MB-231 cell xenograft tumors were treated with low dose (20 mg/kg) and high dose (60 mg/kg) Tan-IIA for 90 days. As a control, mice were treated with corn oil. (A) At the end of the 3-month dosing schedule, the SCID mice were sacrificed by CO~2~ inhalation on the 97th day, and the xenograft tumors were dissected and weighed. (B) The results also showed that high dose (60 mg/kg) of Tan-IIA significantly decreased the weight of MDA-MB-231 cell xenograft tumors when compared to the control group.
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###### 

MDA-MB-231 cell xenograft model treated with Tan-IIA decreased NF-κBp65 expression (A), but increased caspase 3 expression (B) when compared to the control group. Values are expressed as the means ± SD. ^\*^Significant difference at p\<0.05 vs. the control group.
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###### 

Protein expression of Erb-B2, LC3-II, caspase 3 and β-actin in MDA-MB-231 cells treated with Tan-IIA for 48 h. The results showed that MDA-MB-231 cells treated with Tan-IIA for 48 h down-regulated the protein expression of Erb-B2 (A) and LC3-II (B), but increased caspase 3 expression C) *in vitro*. Values are expressed as the means ± SD. ^\*^Significant difference at p\<0.05 vs. the control group.
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